AC Immune S.A. (ACIU) Stock Overview
Explore AC Immune S.A.’s financial performance, market position, analyst ratings, and future outlook.
AC Immune S.A. (ACIU)
Key Financials
Key Financials
Market Cap
270.2M
P/E Ratio
-5.02
EPS (TTM)
$-0.54
ROE
-0.99%
ACIU Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of AC Immune S.A. (NASDAQ: ACIU) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, AC Immune S.A.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ACIU on the NASDAQ shows an RSI of 49.40, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $3.17 for the NASDAQ listing.
Key metrics behind AC Immune S.A.'s NASDAQ-traded stock include a P/E ratio of -5.02 and a market capitalization of 270.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ACIU on the NASDAQ.